Clinical Trial Update: HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma

View source ↗

Summary

This clinical trial, sponsored by Sun Yat-sen University, is recruiting to evaluate HAIC combined with lenvatinib and a PD-1 inhibitor for infiltrative hepatoce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• LENVIMA (lenvatinib)
• PD-1 inhibitor

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma, Lenvatinib | Status: RECRUITING